← Leaderboards
Efi G. Kokkotou
Beth Israel Deaconess Medical Center
$3,467,893
Attributed
$4,630,096
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $867.7K · FY2008–17$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,630,096 · 3
By mechanism
R01$3,938,096 · 2
R21$692,000 · 1
Top collaborators
- Ted J Kaptchuk6 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Ted J Kaptchuk$14,512,344
- Eleftheria Maratos-Flier$8,987,339
- Vetrivelan Ramalingam$4,548,388
- Robert E Gerszten$34,860,502
- Kara Gross Margolis$5,050,186
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsInvestigationMedicalCytokineBaseChronicAffectMediator Of Activation ProteinResponsePathway InteractionsIntestinesPlayPathogenesisMolecularLinkNeuropeptidesBrainGastrointestinal DiseasesGeneticAmericanAcuteInflammationInflammatory Bowel DiseasesColitis
Grant awards (14)
Pre-clinical evaluation of a neutrophil elastase inhibitor for the treatment of inflammatory bowel disease$346,000
R21 · FY2017 · TR · contact PI
Pre-clinical evaluation of a neutrophil elastase inhibitor for the treatment of inflammatory bowel disease$346,000
R21 · FY2016 · TR · contact PI
Omics and Variable Responses to Placebo and Acupuncture in Irritable Bowel Syndro$395,969
R01 · FY2013 · AT · contact PI
Omics and Variable Responses to Placebo and Acupuncture in Irritable Bowel Syndro$413,441
R01 · FY2012 · AT · contact PI
Melanin-Concentrating Hormone as a Novel Mediator of Intestinal Inflammation$318,657
R01 · FY2012 · DK · contact PI
Omics and Variable Responses to Placebo and Acupuncture in Irritable Bowel Syndro$521,646
R01 · FY2011 · AT · contact PI
Melanin-Concentrating Hormone as a Novel Mediator of Intestinal Inflammation$318,657
R01 · FY2011 · DK · contact PI
Omics and Variable Responses to Placebo and Acupuncture in Irritable Bowel Syndro$413,138
R01 · FY2010 · AT · contact PI
Melanin-Concentrating Hormone as a Novel Mediator of Intestinal Inflammation$324,425
R01 · FY2010 · DK · contact PI
Omics and Variable Responses to Placebo and Acupuncture in Irritable Bowel Syndro$130,125
R01 · FY2010 · AT · contact PI
Omics and Variable Responses to Placebo and Acupuncture in Irritable Bowel Syndro$450,088
R01 · FY2009 · AT · contact PI
Melanin-Concentrating Hormone as a Novel Mediator of Intestinal Inflammation$325,125
R01 · FY2009 · DK · contact PI
Melanin-Concentrating Hormone as a Novel Mediator of Intestinal Inflammation$1,700
R01 · FY2009 · DK · contact PI
Melanin-Concentrating Hormone as a Novel Mediator of Intestinal Inflammation$325,125
R01 · FY2008 · DK · contact PI